相关实验视频

Updated: Jun 29, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

脂肪肝疾病的一个有前途的治疗方法:PCSK9抑制剂

Lizhu Han¹, Liuyun Wu², Qinan Yin¹

¹Department of Pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.

Phytomedicine : international journal of phytotherapy and phytopharmacology

|March 28, 2024

概括

蛋白转化酶抑制剂Subtilisin/ Kexin 9型 (PCSK9) 抑制剂通过调节脂质和减少肝损伤,对治疗脂肪肝疾病 (FLD) 有希望. 传统中医药也通过抑制PCSK9.9表现出潜在的治疗效果.

科学领域:

肝病学和脂质代谢肝病学和脂质代谢
药理学和治疗学药理学和治疗学

背景情况:

脂肪肝疾病 (FLD),包括NAFLD和AFLD,是一个全球性的健康问题,具体治疗方法有限.
FLD和高脂血症之间的复杂关系,特别是降脂药物的影响,仍在调查中.
蛋白转化酶子提利辛/素9型 (PCSK9) 是胆固醇稳态的关键调节剂,使其抑制剂成为FLD的潜在治疗剂.

研究的目的:

阐明PCSK9,脂质代谢和FLD之间的关系和机制.
评估PCSK9抑制剂的药理作用和适用性,包括草药,用于FLD治疗.
根据当前的研究,为更新FLD处理协议提供指导.

主要方法:

在主要数据库 (PubMed,Medline,Embase等) 中进行了全面的文献搜索. 在2024年1月30日之前.
关键词包括"脂肪肝"",肝硬化症"",PCSK9"",中国传统医学"和各种相关术语.
审查主要集中在过去五年内发表的研究.

主要成果:

PCSK9通过LDLR依赖和独立的途径影响循环脂质,并可能与新型脂质生成有关.
升高的PCSK9水平与NAFLD严重程度相关,并且在慢性酒精消费者中观察到.
在临床前和临床研究中,PCSK9抑制剂在改善NASH,降低肝硬化和减轻肝损伤方面表现出有效性,包括涉及传统中医药的临床研究.

结论:

PCSK9在FLD病变发生过程中发挥着重要作用.
PCSK9抑制剂为FLD提供了一个有前途的治疗策略,在脂质调节和肝脏健康方面显示出好处.
某些中国传统药物可以通过抑制PCSK9并产生抗炎和抗氧化作用来治疗FLD.

关键词:

酒精性脂肪性肝病 (afld) 是一种脂肪肝疾病 (fld) 是一种肝脏疾病.非酒精性脂肪肝病 (NAFLD) 是一种非酒精性脂肪肝疾病.这是一种PCSK9抑制剂.蛋白转化酶亚提利辛/素9型 (pcsk9) 组传统的中国医药传统的中国医药.

更多相关视频

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: